Met with a family member new to investing who jumped into

New Post Public Reply Private Reply Replies (0) Message Board
petemantx

Met with a family member new to investing who jumped into CTIX recently on my recommendation and as expected he didn't know what to make of last week's correction and the many false messages posted on various boards.  My instruction to him was quite simple - You are in this as an investor, not a trader, so don't worry about short term fluctuations.  THE ONLY information you have to worry about is if we get formal PR from the company regarding negative results from the clinical trials.  Note I said trials, not trial.  Even if we get one bad result (which I am not expecting but which has the possibility of occurring) from a trial we are dealing with 2 !! excellent products that should be proven effective or not NLT about June 1.   We are winners in this investment if either prove successful.  I stressed that no matter what traders or other non-believers in the company, the science behind our products, the mgt, etc. say we will have non questionable empirical data to support our beliefs.  I asked him what he thought our SP would be once the PR comes out that we are requesting KEVETRIN be recognized as a Breakthrough Treatment?

Bottom line -  Shareprice is virtually meaningless (to him) in this investment anytime prior to June as he is in for the long haul, he can try and time future purchases based on whatever system he deems best to secure lowest prices, but whatever he decides always have in the back of his mind the amount the SP could possibly drop (which I now believe is not too much further) versus the amount it could spike should some sort of positive news appear.  I still think we have about a month til any real blockbuster news is forthcoming and I base this on DF making ABSOLUTELY sure of their data before announcing any strong positive results and to me this could occur no earlier than the end of the third cohort.  This is strictly my opinion only.

I also believe that the recent one day crash shows why IMO too many people get too hyped when the price is on a good upswing because they then get just as negatively hyped when it is retreating.  I expect the price to go thru the roof sometime between now and April - I have told my wife I expect our holdings to increase over $1MM in one day between now and late Spring - so a $1 rise in SP over a couple of days to me is expected and not something to go gaga over.  If we jump from $20 to BUYOUT numbers news, which I believe could happen once big pharma realizes the products are legit and they decide to get CTIX as quickly as possible, then I will go gaga myself.

My biggest concern at this time is that big pharma will decide to buy CTIX out prior to late Nov and my holdings will not have become long term for taxation purposes.

The only posts that have me really PO'd over the last week or so are those that try and debunk the science, smear the names of Dr. M and LE, or try and dash the hopes of those with tumors praying that these trials work.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 8

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 4

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 5

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 5

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 10

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 3

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 4

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 4

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 15

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Employee Productivity Through Modern Office Amenities

Updated Category News Views 174

Exploring the Disconnect Between Office Amenities and Employee Needs As companies strive to create optimal work environments, understanding employee priorities in office amenities has become essential. Recent findings highlight disparities between what organizations provide and what employees prioritize. This misalignment could significantly influence productivity and...

Continue Reading
Quoin Pharmaceuticals Secures Major Funding Boost: Details Inside

Updated Category News Views 229

Quoin Pharmaceuticals Secures Significant Financing Quoin Pharmaceuticals Ltd – ADR (NASDAQ: QNRX) has recently seen a remarkable increase in its stock price as investors respond positively to the announcement of a private placement financing reaching up to $104.5 million. The initial agreement with both new and existing institutional investors includes an upfront...

Continue Reading
Concerns Arise Over Judicial Practices Impacting Senegal's Investment

Updated Category News Views 172

Judicial Irregularities in Senegal's Legal System Khadim Ba, a Non-Executive Director at DerMond Oil & Gas, has become a focal point for concerns regarding the judicial system in Senegal. Detained for months, his situation has attracted the attention of legal experts and rights advocates highlighting serious gaps in due process that threaten both human rights and investor...

Continue Reading
interface.ai Welcomes Steve Swanston: A New Era Begins

Updated Category News Views 171

interface.ai Strengthens Its Leadership Team interface.ai, a forefront player in AI innovation for financial services, has recently announced the appointment of Steve Swanston as its new Chief Revenue Officer (CRO). This significant move is aimed at enhancing the company’s mission to transform the banking landscape through advanced Agentic AI technology. Steve Swanston:...

Continue Reading
Baijiayun Honored for Innovative AI Education Product Excellence

Updated Category News Views 43

Overview of the Award Recognition Baijiayun Group Ltd, often referred to simply as Baijiayun, recently achieved a significant milestone by receiving the "2024 Technological Innovative Educational Product" award. This recognition reflects the company's commitment to technological advancement within the educational sector, particularly through artificial intelligence (AI)...

Continue Reading